Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages

OBJECTIVE—The goal of this study was to investigate the mechanisms by which apolipoprotein (apo) A-I, in the lipid-free form or as a constituent of discoidal reconstituted high-density lipoproteins ([A-I]rHDL), inhibits high-glucose–induced redox signaling in human monocyte-derived macrophages (HMDM...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2011-05, Vol.31 (5), p.1192-1200
Hauptverfasser: Tabet, Fatiha, Lambert, Gilles, Cuesta Torres, Luisa F, Hou, Liming, Sotirchos, Irene, Touyz, Rhian M, Jenkins, Alicia J, Barter, Philip J, Rye, Kerry-Anne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1200
container_issue 5
container_start_page 1192
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 31
creator Tabet, Fatiha
Lambert, Gilles
Cuesta Torres, Luisa F
Hou, Liming
Sotirchos, Irene
Touyz, Rhian M
Jenkins, Alicia J
Barter, Philip J
Rye, Kerry-Anne
description OBJECTIVE—The goal of this study was to investigate the mechanisms by which apolipoprotein (apo) A-I, in the lipid-free form or as a constituent of discoidal reconstituted high-density lipoproteins ([A-I]rHDL), inhibits high-glucose–induced redox signaling in human monocyte-derived macrophages (HMDM). METHODS AND RESULTS—HMDM were incubated under normal (5.8 mmol/L) or high-glucose (25 mmol/L) conditions with native high-density lipoproteins (HDL) lipid-free apoA-I from normal subjects and from subjects with type 2 diabetes (T2D) or (A-I)rHDL. Superoxide (O2) production was measured using dihydroethidium fluorescence. NADPH oxidase activity was assessed using lucigenin-derived chemiluminescence and a cyotochrome c assay. p47phox translocation to the plasma membrane, Nox2, superoxide dismutase 1 (SOD1), and SOD2 mRNA and protein levels were determined by real-time polymerase chain reaction and Western blotting. Native HDL induced a time-dependent inhibition of O2 generation in HMDM incubated with 25 mmol/L glucose. Lipid-free apoA-I and (A-I)rHDL increased SOD1 and SOD2 levels and attenuated 25 mmol/L glucose-mediated increases in cellular O2, NADPH oxidase activity, p47 translocation, and Nox2 expression. Lipid-free apoA-I mediated its effects on Nox2, SOD1, and SOD2 via ABCA1. (A-I)rHDL-mediated effects were via ABCG1 and scavenger receptor BI. Lipid-free apoA-I from subjects with T2D inhibited reactive oxygen species generation less efficiently than normal apoA-I. CONCLUSION—Native HDL, lipid-free apoA-I and (A-I)rHDL inhibit high-glucose–induced redox signaling in HMDM. The antioxidant properties of apoA-I are attenuated in T2D.
doi_str_mv 10.1161/ATVBAHA.110.222000
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_863423725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>863423725</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4230-ed9f722a0f49d35c707e48fe1c3d05c3bde14bd94c66c0e2154d45c65bcae4a63</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSMEon-8AAvkDWKV4v90lqGlnZEGVYKWbeTYN43BY6e2Q5m36aPiaga6Y2Vf6TvnnqtTVW8JPiVEko_tzfdP7bItAz6llGKMX1SHRFBec8nky_LHzaIWktOD6iilHwXgBXtdHVDCGJaYHVaPaztZU19GANROwdkpTDFksB619Qopb9CFTTpYoxz6Cjr4lG2eMxi0tHdjfQE-2bxF62dhKophgAg-W-XcFq38aHub0ZWbdUhQr7yZdTG4_l1cs_0F6FuOkBIqS5fzRnn0RekYplHdQTqpXg3KJXizf4-r28vPN-fLen19tTpv17XmlOEazGJoKFV44AvDhG5wA_xsAKKZwUKz3gDhvVlwLaXGQInghgstRa8VcCXZcfVh51uuuJ8h5W5T7gbnlIcwp-5MsrKooaKQdEeWjClFGLop2o2K247g7qmYbl9MGXC3K6aI3u3t534D5p_kbxMFeL8HVNLKDVF5bdMzxwnhgj3llDvuIbgMMf108wPEbgTl8vi_BH8ArVSqsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>863423725</pqid></control><display><type>article</type><title>Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Tabet, Fatiha ; Lambert, Gilles ; Cuesta Torres, Luisa F ; Hou, Liming ; Sotirchos, Irene ; Touyz, Rhian M ; Jenkins, Alicia J ; Barter, Philip J ; Rye, Kerry-Anne</creator><creatorcontrib>Tabet, Fatiha ; Lambert, Gilles ; Cuesta Torres, Luisa F ; Hou, Liming ; Sotirchos, Irene ; Touyz, Rhian M ; Jenkins, Alicia J ; Barter, Philip J ; Rye, Kerry-Anne</creatorcontrib><description>OBJECTIVE—The goal of this study was to investigate the mechanisms by which apolipoprotein (apo) A-I, in the lipid-free form or as a constituent of discoidal reconstituted high-density lipoproteins ([A-I]rHDL), inhibits high-glucose–induced redox signaling in human monocyte-derived macrophages (HMDM). METHODS AND RESULTS—HMDM were incubated under normal (5.8 mmol/L) or high-glucose (25 mmol/L) conditions with native high-density lipoproteins (HDL) lipid-free apoA-I from normal subjects and from subjects with type 2 diabetes (T2D) or (A-I)rHDL. Superoxide (O2) production was measured using dihydroethidium fluorescence. NADPH oxidase activity was assessed using lucigenin-derived chemiluminescence and a cyotochrome c assay. p47phox translocation to the plasma membrane, Nox2, superoxide dismutase 1 (SOD1), and SOD2 mRNA and protein levels were determined by real-time polymerase chain reaction and Western blotting. Native HDL induced a time-dependent inhibition of O2 generation in HMDM incubated with 25 mmol/L glucose. Lipid-free apoA-I and (A-I)rHDL increased SOD1 and SOD2 levels and attenuated 25 mmol/L glucose-mediated increases in cellular O2, NADPH oxidase activity, p47 translocation, and Nox2 expression. Lipid-free apoA-I mediated its effects on Nox2, SOD1, and SOD2 via ABCA1. (A-I)rHDL-mediated effects were via ABCG1 and scavenger receptor BI. Lipid-free apoA-I from subjects with T2D inhibited reactive oxygen species generation less efficiently than normal apoA-I. CONCLUSION—Native HDL, lipid-free apoA-I and (A-I)rHDL inhibit high-glucose–induced redox signaling in HMDM. The antioxidant properties of apoA-I are attenuated in T2D.</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/ATVBAHA.110.222000</identifier><identifier>PMID: 21330603</identifier><identifier>CODEN: ATVBFA</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Apolipoprotein A-I - metabolism ; Atherosclerosis (general aspects, experimental research) ; ATP Binding Cassette Transporter 1 ; ATP Binding Cassette Transporter, Sub-Family G, Member 1 ; ATP-Binding Cassette Transporters - genetics ; ATP-Binding Cassette Transporters - metabolism ; Biological and medical sciences ; Blood and lymphatic vessels ; Blotting, Western ; Cardiology. Vascular system ; Case-Control Studies ; Cells, Cultured ; Diabetes Mellitus, Type 2 - immunology ; Diabetes Mellitus, Type 2 - metabolism ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Enzyme Inhibitors - pharmacology ; General and cellular metabolism. Vitamins ; Glucose - metabolism ; Humans ; Lipoproteins - metabolism ; Lipoproteins, HDL - metabolism ; Macrophages - drug effects ; Macrophages - immunology ; Macrophages - metabolism ; Medical sciences ; Membrane Glycoproteins - antagonists &amp; inhibitors ; Membrane Glycoproteins - genetics ; Membrane Glycoproteins - metabolism ; NADPH Oxidase 2 ; NADPH Oxidases - antagonists &amp; inhibitors ; NADPH Oxidases - genetics ; NADPH Oxidases - metabolism ; Oxidative Stress - drug effects ; Pharmacology. Drug treatments ; Protein Transport ; Reverse Transcriptase Polymerase Chain Reaction ; RNA Interference ; RNA, Messenger - metabolism ; Scavenger Receptors, Class B - genetics ; Scavenger Receptors, Class B - metabolism ; Signal Transduction ; Superoxide Dismutase - genetics ; Superoxide Dismutase - metabolism ; Superoxide Dismutase-1 ; Superoxides - metabolism ; Time Factors ; Transfection</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2011-05, Vol.31 (5), p.1192-1200</ispartof><rights>2011 American Heart Association, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4230-ed9f722a0f49d35c707e48fe1c3d05c3bde14bd94c66c0e2154d45c65bcae4a63</citedby><cites>FETCH-LOGICAL-c4230-ed9f722a0f49d35c707e48fe1c3d05c3bde14bd94c66c0e2154d45c65bcae4a63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24114536$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21330603$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tabet, Fatiha</creatorcontrib><creatorcontrib>Lambert, Gilles</creatorcontrib><creatorcontrib>Cuesta Torres, Luisa F</creatorcontrib><creatorcontrib>Hou, Liming</creatorcontrib><creatorcontrib>Sotirchos, Irene</creatorcontrib><creatorcontrib>Touyz, Rhian M</creatorcontrib><creatorcontrib>Jenkins, Alicia J</creatorcontrib><creatorcontrib>Barter, Philip J</creatorcontrib><creatorcontrib>Rye, Kerry-Anne</creatorcontrib><title>Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVE—The goal of this study was to investigate the mechanisms by which apolipoprotein (apo) A-I, in the lipid-free form or as a constituent of discoidal reconstituted high-density lipoproteins ([A-I]rHDL), inhibits high-glucose–induced redox signaling in human monocyte-derived macrophages (HMDM). METHODS AND RESULTS—HMDM were incubated under normal (5.8 mmol/L) or high-glucose (25 mmol/L) conditions with native high-density lipoproteins (HDL) lipid-free apoA-I from normal subjects and from subjects with type 2 diabetes (T2D) or (A-I)rHDL. Superoxide (O2) production was measured using dihydroethidium fluorescence. NADPH oxidase activity was assessed using lucigenin-derived chemiluminescence and a cyotochrome c assay. p47phox translocation to the plasma membrane, Nox2, superoxide dismutase 1 (SOD1), and SOD2 mRNA and protein levels were determined by real-time polymerase chain reaction and Western blotting. Native HDL induced a time-dependent inhibition of O2 generation in HMDM incubated with 25 mmol/L glucose. Lipid-free apoA-I and (A-I)rHDL increased SOD1 and SOD2 levels and attenuated 25 mmol/L glucose-mediated increases in cellular O2, NADPH oxidase activity, p47 translocation, and Nox2 expression. Lipid-free apoA-I mediated its effects on Nox2, SOD1, and SOD2 via ABCA1. (A-I)rHDL-mediated effects were via ABCG1 and scavenger receptor BI. Lipid-free apoA-I from subjects with T2D inhibited reactive oxygen species generation less efficiently than normal apoA-I. CONCLUSION—Native HDL, lipid-free apoA-I and (A-I)rHDL inhibit high-glucose–induced redox signaling in HMDM. The antioxidant properties of apoA-I are attenuated in T2D.</description><subject>Apolipoprotein A-I - metabolism</subject><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>ATP Binding Cassette Transporter 1</subject><subject>ATP Binding Cassette Transporter, Sub-Family G, Member 1</subject><subject>ATP-Binding Cassette Transporters - genetics</subject><subject>ATP-Binding Cassette Transporters - metabolism</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blotting, Western</subject><subject>Cardiology. Vascular system</subject><subject>Case-Control Studies</subject><subject>Cells, Cultured</subject><subject>Diabetes Mellitus, Type 2 - immunology</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>General and cellular metabolism. Vitamins</subject><subject>Glucose - metabolism</subject><subject>Humans</subject><subject>Lipoproteins - metabolism</subject><subject>Lipoproteins, HDL - metabolism</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Macrophages - metabolism</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - antagonists &amp; inhibitors</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>NADPH Oxidase 2</subject><subject>NADPH Oxidases - antagonists &amp; inhibitors</subject><subject>NADPH Oxidases - genetics</subject><subject>NADPH Oxidases - metabolism</subject><subject>Oxidative Stress - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Transport</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA Interference</subject><subject>RNA, Messenger - metabolism</subject><subject>Scavenger Receptors, Class B - genetics</subject><subject>Scavenger Receptors, Class B - metabolism</subject><subject>Signal Transduction</subject><subject>Superoxide Dismutase - genetics</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Superoxide Dismutase-1</subject><subject>Superoxides - metabolism</subject><subject>Time Factors</subject><subject>Transfection</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhSMEon-8AAvkDWKV4v90lqGlnZEGVYKWbeTYN43BY6e2Q5m36aPiaga6Y2Vf6TvnnqtTVW8JPiVEko_tzfdP7bItAz6llGKMX1SHRFBec8nky_LHzaIWktOD6iilHwXgBXtdHVDCGJaYHVaPaztZU19GANROwdkpTDFksB619Qopb9CFTTpYoxz6Cjr4lG2eMxi0tHdjfQE-2bxF62dhKophgAg-W-XcFq38aHub0ZWbdUhQr7yZdTG4_l1cs_0F6FuOkBIqS5fzRnn0RekYplHdQTqpXg3KJXizf4-r28vPN-fLen19tTpv17XmlOEazGJoKFV44AvDhG5wA_xsAKKZwUKz3gDhvVlwLaXGQInghgstRa8VcCXZcfVh51uuuJ8h5W5T7gbnlIcwp-5MsrKooaKQdEeWjClFGLop2o2K247g7qmYbl9MGXC3K6aI3u3t534D5p_kbxMFeL8HVNLKDVF5bdMzxwnhgj3llDvuIbgMMf108wPEbgTl8vi_BH8ArVSqsg</recordid><startdate>201105</startdate><enddate>201105</enddate><creator>Tabet, Fatiha</creator><creator>Lambert, Gilles</creator><creator>Cuesta Torres, Luisa F</creator><creator>Hou, Liming</creator><creator>Sotirchos, Irene</creator><creator>Touyz, Rhian M</creator><creator>Jenkins, Alicia J</creator><creator>Barter, Philip J</creator><creator>Rye, Kerry-Anne</creator><general>American Heart Association, Inc</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201105</creationdate><title>Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages</title><author>Tabet, Fatiha ; Lambert, Gilles ; Cuesta Torres, Luisa F ; Hou, Liming ; Sotirchos, Irene ; Touyz, Rhian M ; Jenkins, Alicia J ; Barter, Philip J ; Rye, Kerry-Anne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4230-ed9f722a0f49d35c707e48fe1c3d05c3bde14bd94c66c0e2154d45c65bcae4a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Apolipoprotein A-I - metabolism</topic><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>ATP Binding Cassette Transporter 1</topic><topic>ATP Binding Cassette Transporter, Sub-Family G, Member 1</topic><topic>ATP-Binding Cassette Transporters - genetics</topic><topic>ATP-Binding Cassette Transporters - metabolism</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blotting, Western</topic><topic>Cardiology. Vascular system</topic><topic>Case-Control Studies</topic><topic>Cells, Cultured</topic><topic>Diabetes Mellitus, Type 2 - immunology</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>General and cellular metabolism. Vitamins</topic><topic>Glucose - metabolism</topic><topic>Humans</topic><topic>Lipoproteins - metabolism</topic><topic>Lipoproteins, HDL - metabolism</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Macrophages - metabolism</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - antagonists &amp; inhibitors</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>NADPH Oxidase 2</topic><topic>NADPH Oxidases - antagonists &amp; inhibitors</topic><topic>NADPH Oxidases - genetics</topic><topic>NADPH Oxidases - metabolism</topic><topic>Oxidative Stress - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Transport</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA Interference</topic><topic>RNA, Messenger - metabolism</topic><topic>Scavenger Receptors, Class B - genetics</topic><topic>Scavenger Receptors, Class B - metabolism</topic><topic>Signal Transduction</topic><topic>Superoxide Dismutase - genetics</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Superoxide Dismutase-1</topic><topic>Superoxides - metabolism</topic><topic>Time Factors</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tabet, Fatiha</creatorcontrib><creatorcontrib>Lambert, Gilles</creatorcontrib><creatorcontrib>Cuesta Torres, Luisa F</creatorcontrib><creatorcontrib>Hou, Liming</creatorcontrib><creatorcontrib>Sotirchos, Irene</creatorcontrib><creatorcontrib>Touyz, Rhian M</creatorcontrib><creatorcontrib>Jenkins, Alicia J</creatorcontrib><creatorcontrib>Barter, Philip J</creatorcontrib><creatorcontrib>Rye, Kerry-Anne</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tabet, Fatiha</au><au>Lambert, Gilles</au><au>Cuesta Torres, Luisa F</au><au>Hou, Liming</au><au>Sotirchos, Irene</au><au>Touyz, Rhian M</au><au>Jenkins, Alicia J</au><au>Barter, Philip J</au><au>Rye, Kerry-Anne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2011-05</date><risdate>2011</risdate><volume>31</volume><issue>5</issue><spage>1192</spage><epage>1200</epage><pages>1192-1200</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><coden>ATVBFA</coden><abstract>OBJECTIVE—The goal of this study was to investigate the mechanisms by which apolipoprotein (apo) A-I, in the lipid-free form or as a constituent of discoidal reconstituted high-density lipoproteins ([A-I]rHDL), inhibits high-glucose–induced redox signaling in human monocyte-derived macrophages (HMDM). METHODS AND RESULTS—HMDM were incubated under normal (5.8 mmol/L) or high-glucose (25 mmol/L) conditions with native high-density lipoproteins (HDL) lipid-free apoA-I from normal subjects and from subjects with type 2 diabetes (T2D) or (A-I)rHDL. Superoxide (O2) production was measured using dihydroethidium fluorescence. NADPH oxidase activity was assessed using lucigenin-derived chemiluminescence and a cyotochrome c assay. p47phox translocation to the plasma membrane, Nox2, superoxide dismutase 1 (SOD1), and SOD2 mRNA and protein levels were determined by real-time polymerase chain reaction and Western blotting. Native HDL induced a time-dependent inhibition of O2 generation in HMDM incubated with 25 mmol/L glucose. Lipid-free apoA-I and (A-I)rHDL increased SOD1 and SOD2 levels and attenuated 25 mmol/L glucose-mediated increases in cellular O2, NADPH oxidase activity, p47 translocation, and Nox2 expression. Lipid-free apoA-I mediated its effects on Nox2, SOD1, and SOD2 via ABCA1. (A-I)rHDL-mediated effects were via ABCG1 and scavenger receptor BI. Lipid-free apoA-I from subjects with T2D inhibited reactive oxygen species generation less efficiently than normal apoA-I. CONCLUSION—Native HDL, lipid-free apoA-I and (A-I)rHDL inhibit high-glucose–induced redox signaling in HMDM. The antioxidant properties of apoA-I are attenuated in T2D.</abstract><cop>Philadelphia, PA</cop><pub>American Heart Association, Inc</pub><pmid>21330603</pmid><doi>10.1161/ATVBAHA.110.222000</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 2011-05, Vol.31 (5), p.1192-1200
issn 1079-5642
1524-4636
language eng
recordid cdi_proquest_miscellaneous_863423725
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Apolipoprotein A-I - metabolism
Atherosclerosis (general aspects, experimental research)
ATP Binding Cassette Transporter 1
ATP Binding Cassette Transporter, Sub-Family G, Member 1
ATP-Binding Cassette Transporters - genetics
ATP-Binding Cassette Transporters - metabolism
Biological and medical sciences
Blood and lymphatic vessels
Blotting, Western
Cardiology. Vascular system
Case-Control Studies
Cells, Cultured
Diabetes Mellitus, Type 2 - immunology
Diabetes Mellitus, Type 2 - metabolism
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Enzyme Inhibitors - pharmacology
General and cellular metabolism. Vitamins
Glucose - metabolism
Humans
Lipoproteins - metabolism
Lipoproteins, HDL - metabolism
Macrophages - drug effects
Macrophages - immunology
Macrophages - metabolism
Medical sciences
Membrane Glycoproteins - antagonists & inhibitors
Membrane Glycoproteins - genetics
Membrane Glycoproteins - metabolism
NADPH Oxidase 2
NADPH Oxidases - antagonists & inhibitors
NADPH Oxidases - genetics
NADPH Oxidases - metabolism
Oxidative Stress - drug effects
Pharmacology. Drug treatments
Protein Transport
Reverse Transcriptase Polymerase Chain Reaction
RNA Interference
RNA, Messenger - metabolism
Scavenger Receptors, Class B - genetics
Scavenger Receptors, Class B - metabolism
Signal Transduction
Superoxide Dismutase - genetics
Superoxide Dismutase - metabolism
Superoxide Dismutase-1
Superoxides - metabolism
Time Factors
Transfection
title Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T09%3A13%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipid-Free%20Apolipoprotein%20A-I%20and%20Discoidal%20Reconstituted%20High-Density%20Lipoproteins%20Differentially%20Inhibit%20Glucose-Induced%20Oxidative%20Stress%20in%20Human%20Macrophages&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Tabet,%20Fatiha&rft.date=2011-05&rft.volume=31&rft.issue=5&rft.spage=1192&rft.epage=1200&rft.pages=1192-1200&rft.issn=1079-5642&rft.eissn=1524-4636&rft.coden=ATVBFA&rft_id=info:doi/10.1161/ATVBAHA.110.222000&rft_dat=%3Cproquest_cross%3E863423725%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=863423725&rft_id=info:pmid/21330603&rfr_iscdi=true